Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Bromhexine hydrochloride 0.8 mg/mL, pholcodine 1 mg/mL Syrup 3M Pharmaceuticals (Australia) Pty Limited, Thornleigh, New South Wales, Australia Duro-Tuss Expectorant Succinylated gelatin 40g/L Infusion, solution B Braun Medical AG., St. Gallen, Switzerland Gelofusine Hydrocortisone acetate 0.5% w/w Cream, topical Taro Pharmaceuticals Inc., Bramelea, Ontario, Canada Hydrocortisone Cream 1/2% Hydrocortisone acetate 1% w/w Cream, topical Taro Pharmaceuticals Inc., Bramelea, Ontario, Canada Hydrocortisone Cream 1% Rituximab 10 mg/mL Infusion, concentrate IDEC Pharmaceuticals Corporation, San Diego, California, United States of America Mabthera Dated this 4th day of March 1999. GILLIAN GREW, Chief Advisor, Regulation and Safety (acting), pursuant to delegation given by the Minister of Health on the 20th day of February 1997.